The scientist’s investigation covers issues in Ophthalmology, Macular degeneration, Retina, Retinal and Surgery. His work deals with themes such as Retinopathy and Maculopathy, which intersect with Ophthalmology. His Macular degeneration research incorporates elements of Retinal pigment epithelium, Choroid, Ranibizumab and Atrophy.
Sebastian Wolf combines subjects such as Endocrinology, Optical coherence tomography, Blood flow, Anatomy and Hemodynamics with his study of Retina. His Retinal research integrates issues from Autofluorescence, Glutamate receptor, Optometry, Pathology and Internal medicine. His Surgery research is multidisciplinary, incorporating elements of Topical medication, Panretinal photocoagulation, Blood pressure and Intravitreal bevacizumab.
His primary areas of study are Ophthalmology, Retinal, Macular degeneration, Surgery and Visual acuity. His Ophthalmology research incorporates themes from Retinopathy and Ranibizumab. His research combines Eye disease and Retinopathy.
His work focuses on many connections between Retinal and other disciplines, such as Autofluorescence, that overlap with his field of interest in Pathology. His research in Macular degeneration intersects with topics in Optometry, Regimen, Aflibercept and Age related. His Fluorescein angiography research is multidisciplinary, relying on both Diabetic retinopathy, Maculopathy, Ophthalmoscopy, Angiography and Microcirculation.
Sebastian Wolf spends much of his time researching Ophthalmology, Retinal, Macular degeneration, Optical coherence tomography and Visual acuity. His study in the field of Choroidal neovascularization also crosses realms of In patient. The Retinal study combines topics in areas such as Autofluorescence, Retina and Artificial intelligence.
His studies deal with areas such as Retrospective cohort study, Treat and extend regimen, Immunology and Age related as well as Macular degeneration. His Optical coherence tomography research focuses on Biomedical engineering and how it connects with Wide field. His Visual acuity study combines topics from a wide range of disciplines, such as Pro re nata, Adverse effect and Randomized controlled trial.
Sebastian Wolf focuses on Ophthalmology, Retinal, Visual acuity, Macular degeneration and Optical coherence tomography. His research integrates issues of Diabetic retinopathy, Ranibizumab and Retrospective cohort study in his study of Ophthalmology. Sebastian Wolf interconnects Retina, Autofluorescence and Artificial intelligence in the investigation of issues within Retinal.
Treat and extend regimen is closely connected to Regimen in his research, which is encompassed under the umbrella topic of Visual acuity. His study looks at the relationship between Macular degeneration and fields such as Clinical trial, as well as how they intersect with chemical problems. The study incorporates disciplines such as Nuclear medicine, Perimeter and Medical imaging in addition to Optical coherence tomography.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study
Pascale Massin;Francesco Bandello;Justus G. Garweg;Lutz L. Hansen.
Diabetes Care (2010)
A new variable stiffness design: Matching requirements of the next robot generation
S. Wolf;G. Hirzinger.
international conference on robotics and automation (2008)
Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments.
Ute Ek Wolf-Schnurrbusch;Lala Ceklic;Christian Karl Brinkmann;Milko Iliev.
Investigative Ophthalmology & Visual Science (2009)
Growth Control and Cell Wall Signaling in Plants
Sebastian Wolf;Kian Hematy;Hermanus Höfte.
Annual Review of Plant Biology (2012)
The DLR hand arm system
Markus Grebenstein;Alin Albu-Schaffer;Thomas Bahls;Maxime Chalon.
international conference on robotics and automation (2011)
Homogalacturonan methyl-esterification and plant development.
Sebastian Wolf;Grégory Mouille;Jérome Pelloux.
Molecular Plant (2009)
Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network.
O Arend;S Wolf;F Jung;B Bertram.
British Journal of Ophthalmology (1991)
Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
Paul Mitchell;Jean-François Korobelnik;P Lanzetta;Frank G Holz.
British Journal of Ophthalmology (2010)
Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3.
Srinivas R. Sadda;Robyn Guymer;Frank G. Holz;Steffen Schmitz-Valckenberg.
Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma.
Milko E. Iliev;Diego Domig;Ute Wolf-Schnurrbursch;Sebastian Wolf.
American Journal of Ophthalmology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: